Multi-center comparison between proton and photon plans for mediastinal lymphomas

References

• Specht L, Yahalom J, Illidge T, et al. Modern radiation therapy for Hodgkin lymphoma: field and dose guidelines from the international lymphoma radiation oncology group (ILROG). Int J Radiat Oncol Biol Phys. 2014;89(4):854–862. doi:10.1016/j.ijrobp.2013.05.005.
   PubMed Web of Science ®Google Scholar
• Buglione M, Guerini AE, Filippi AR, et al. A systematic review on intensity modulated radiation therapy for mediastinal hodgkin’s lymphoma. Crit Rev Oncol Hematol. 2021;167:103437. doi:10.1016/j.critrevonc.2021.103437.
   PubMed Web of Science ®Google Scholar
• Aznar MC, Maraldo MV, Schut DA, et al. Minimizing late effects for patients with mediastinal hodgkin lymphoma: deep inspiration breath-hold, IMRT, or both? Int J Radiat Oncol Biol Phys. 2015;92(1):169–174. doi:10.1016/j.ijrobp.2015.01.013.
   PubMed Web of Science ®Google Scholar
• Travis LB, Gospodarowicz M, Curtis RE, et al. Lung cancer following chemotherapy and radiotherapy for Hodgkin’s disease. J Natl Cancer Inst. 2002;94(3):182–192. doi:10.1093/jnci/94.3.182.
   PubMedGoogle Scholar
• van Nimwegen FA, Schaapveld M, Cutter DJ, et al. Radiation dose-response relationship for risk of coronary heart disease in survivors of Hodgkin lymphoma. J Clin Oncol. 2016;34(3):235–243. doi:10.1200/JCO.2015.63.4444.
   PubMed Web of Science ®Google Scholar
• Travis LB, Hill DA, Dores GM, et al. Breast cancer following radiotherapy and chemotherapy among young women with Hodgkin disease. JAMA. 2003;290(4):465–475. doi:10.1001/jama.290.4.465.
   PubMed Web of Science ®Google Scholar
• Jaglowski SM, Linden E, Termuhlen AM, et al. Lymphoma in adolescents and young adults. Semin Oncol. 2009;36(5):381–418. doi:10.1053/j.seminoncol.2009.07.009.
   PubMed Web of Science ®Google Scholar
• National Cancer Institute. Cancer Stat Facts: Hodgkin Lymphoma. Surveillance, Epidemiology, and End Results Program (SEER). 2022. Available from: https://seer.cancer.gov/statfacts/html/hodg.html.
   Google Scholar
• Dabaja BS, Hoppe BS, Plastaras JP, et al. Proton therapy for adults with mediastinal lymphomas: the International Lymphoma Radiation Oncology Group guidelines. Blood. 2018;132(16):1635–1646. doi:10.1182/blood-2018-03-837633.
   PubMed Web of Science ®Google Scholar
• Chera BS, Rodriguez C, Morris CG, et al. Dosimetric comparison of three different involved nodal irradiation techniques for stage II Hodgkin’s lymphoma patients: conventional radiotherapy, intensity-modulated radiotherapy, and three-dimensional proton radiotherapy. Int J Radiat Oncol Biol Phys. 2009;75(4):1173–1180. doi:10.1016/j.ijrobp.2008.12.048.
   PubMed Web of Science ®Google Scholar
• Baues C, Marnitz S, Engert A, et al. Proton versus photon deep inspiration breath hold technique in patients with hodgkin lymphoma and mediastinal radiation. Radiat Oncol. 2018;13(1):122. doi:10.1186/s13014-018-1066-2.
   PubMedGoogle Scholar
• Hoppe BS, Flampouri S, Su Z, et al. Consolidative involved-node proton therapy for stage IA-IIIB mediastinal Hodgkin lymphoma: preliminary dosimetric outcomes from a phase II study. Int J Radiat Oncol Biol Phys. 2012;83(1):260–267. doi:10.1016/j.ijrobp.2011.06.1959.
   PubMed Web of Science ®Google Scholar
• Edvardsson A, Kügele M, Alkner S, et al. Comparative treatment planning study for mediastinal Hodgkin’s lymphoma: impact on normal tissue dose using deep inspiration breath hold proton and photon therapy. Acta Oncol. 2019;58(1):95–104. doi:10.1080/0284186X.2018.1512153.
   PubMed Web of Science ®Google Scholar
• Rechner LA, Maraldo MV, Vogelius IR, et al. Life years lost attributable to late effects after radiotherapy for early stage Hodgkin lymphoma: the impact of proton therapy and/or deep inspiration breath hold. Radiother Oncol. 2017;125(1):41–47. doi:10.1016/j.radonc.2017.07.033.
   PubMed Web of Science ®Google Scholar
• Patel CG, Peterson J, Aznar M, et al. Systematic review for deep inspiration breath hold in proton therapy for mediastinal lymphoma: a PTCOG Lymphoma Subcommittee report and recommendations. Radiother Oncol. 2022;177:21–32. doi:10.1016/j.radonc.2022.10.003.
   PubMed Web of Science ®Google Scholar
• Paganetti H, Botas P, Sharp GC, et al. Adaptive proton therapy. Phys Med Biol. 2021;66(22):22TR01. doi:10.1088/1361-6560/ac344f.
   Web of Science ®Google Scholar
• Chang JY, Zhang X, Knopf A, et al. Consensus guidelines for implementing pencil-beam scanning proton therapy for thoracic malignancies on behalf of the PTCOG thoracic and lymphoma subcommittee. Int J Radiat Oncol Biol Phys. 2017;99(1):41–50. doi:10.1016/j.ijrobp.2017.05.014.
   PubMed Web of Science ®Google Scholar
• DLG: Kliniske retningslinjer for Hodgkin lymfom, version 1.0. 2022. Available from: https://www.lymphoma.dk/retningslinjer.
   Google Scholar
• Vega RBM, Mohammadi H, Patel SI, et al. Establishing cost-effective allocation of proton therapy for patients with mediastinal Hodgkin lymphoma. Int J Radiat Oncol Biol Phys. 2022;112(1):158–166. doi:10.1016/j.ijrobp.2021.07.1711.
   PubMed Web of Science ®Google Scholar
• Centers for Disease Control and Prevention (CDC ). Prevalence of coronary heart disease–United States, 2006–2010. MMWR Morb Mortal Wkly Rep. 2011;60(40):1377–1381.
   PubMedGoogle Scholar